Terms: = Endocrine gland cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Staging
4 results:
1. ctnnb1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
[TBL] [Abstract] [Full Text] [Related]
2. Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers.
Guerra F; Girolimetti G; Perrone AM; Procaccini M; Kurelac I; Ceccarelli C; De Biase D; Caprara G; Zamagni C; De Iaco P; Santini D; Gasparre G
Mod Pathol; 2014 Oct; 27(10):1412-20. PubMed ID: 24633194
[TBL] [Abstract] [Full Text] [Related]
3. [Childhood adrenocortical tumors: from a clinical to a molecular approach].
Antonini SR; Colli LM; Ferro L; Mermejo L; Castro Md
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):599-606. PubMed ID: 22218442
[TBL] [Abstract] [Full Text] [Related]
4. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE
Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235
[TBL] [Abstract] [Full Text] [Related]
